Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The landscape of abnormal pathway activation confers COVID-19 patients' molecular sequelae earlier than clinical phenotype.

Theranostics - 1 Jan 2023

Zhang Xiuli, Sh Yuan, Dong Jierong, Chen Zhongqing, Hong Feitong

Abstract excerpt

Rationale: The 2019 coronavirus disease (COVID-19) pandemic poses a significant threat to human health. After SARS-CoV-2 infection, major clinical concerns are organ damage and possible sequelae. Methods: In this study, we analyzed serum multi-omics data based on population-level, including healthy cohort, non-COVID-19 and COVID-19 covered different severity cohorts. We applied the pseudo-SpatioTemporal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19
Share to Lung
Share to Molecular Docking Simulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to SARS-CoV-2

Source

Open in PubMed Open full text

Identifiers

PMID: 37351167
DOI: 10.7150/thno.83405
PMCID: PMC10283057

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The landscape of abnormal pathway activation confers COVID-19 patients' molecular sequelae earlier than clinical phenotype.PMID 37351167Read ↗

Plasma proteomics identify potential severity biomarkers from COVID‐19 associated networkSemantic proximity Read ↗

Molecular signatures in the progression of COVID-19 severitySemantic proximity Read ↗

Secondary analysis of transcriptomes of SARS-CoV-2 infection models to characterize COVID-19Semantic proximity Read ↗

Prediction of severe adverse events, modes of action and drug treatments for COVID-19's complications.Semantic proximity Read ↗

Systems Biology and Bioinformatics approach to Identify blood based signatures molecules and drug targets of patient with COVID-19Semantic proximity Read ↗

In Silico transcriptional analysis of asymptomatic and severe COVID-19 patients reveals the susceptibility of severe patients to other comorbidities and non-viral pathological conditionsSemantic proximity Read ↗

Dynamic gene expression analysis reveals distinct severity phases of immune and cellular dysregulation in COVID-19Semantic proximity Read ↗

Clinical phenotypes and features of the post-COVID syndrome courseSemantic proximity Read ↗

Phenome-wide association of 1809 phenotypes and COVID-19 disease progression in the Veterans Health Administration Million Veteran ProgramSemantic proximity Read ↗

MOATAI-VIR - an AI algorithm that predicts severe adverse events and molecular features for COVID-19’s complicationsSemantic proximity Read ↗

A blood-based comprehensive and systems-level analysis of disease stages, immune regulation and symptoms in COVID-19 patientsSemantic proximity Read ↗

Uncovering the Pathophysiological Pattern of Expression from Integrated Analysis across Uniformly Processed RNA Sequencing COVID-19 DatasetsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.